Omitting Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Patients

被引：0

作者：

Thompson, Danielle ^{[1
,2
]}

Yao, Katharine ^{[1
,3
]}

机构：

[1] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL 60201 USA

[2] Univ Chicago, Dept Surg, Chicago, IL USA

[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA

来源：

CURRENT BREAST CANCER REPORTS | 2024年 / 16卷 / 03期

关键词：

Breast cancer; Sentinel lymph node biopsy; Axillary lymph node biopsy; Omission; De-escalation; STANDARD AXILLARY TREATMENT; CARCINOMA IN-SITU; RADICAL-MASTECTOMY; ELDERLY-WOMEN; DISSECTION; TRIAL; OLDER; MULTICENTER; IRRADIATION; PROTOCOL;

D O I：

10.1007/s12609-024-00557-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of ReviewTo describe current research regarding omission of sentinel lymph node biopsy (SLNB) in breast cancer patients.Recent FindingsResults from a recent clinical trial, the SOUND trial, with results pending from trials such as NAUTILUS, INSEMA and BOOG 2013-08, suggest that the omission of SLNB in patients with T1-2 N0 invasive breast cancer is oncologically safe and has noninferior 5-year distant disease-free survival compared to those who underwent SLNB +/- ALND. Best practice guidelines do recommend omitting SLNB for older patients with estrogen receptor invasive breast cancers and for most patients undergoing surgery for ductal carcinoma in situ.SummaryAxillary surgery continues to evolve over time to less surgery in the axilla for patients with both invasive and noninvasive disease. Changes in adjuvant therapy, increased use of genomic testing and axillary US have all impacted this trend.

引用

页码：302 / 310

页数：9

共 38 条

[1] Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis [J].

Alamoodi, Munaser ;

Wazir, Umar ;

Mokbel, Kinan ;

Patani, Neill ;

Varghese, Jajini ;

Mokbel, Kefah .

CANCERS, 2023, 15 (13)

[2] Are we choosing wisely in elderly females with breast cancer? [J].

Calderon, Esteban ;

Webb, Christopher ;

Kosiorek, Heidi E. ;

Gray, M. D. Richard J. ;

Cronin, Patricia ;

Anderson, Karen ;

Northfelt, Donald ;

McCullough, Ann ;

Ocal, Idris Tolgay ;

Pockaj, Barbara .

AMERICAN JOURNAL OF SURGERY, 2019, 218 (06) :1229-1233

[3] Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer [J].

Carleton, Neil ;

Zou, Jian ;

Fang, Yusi ;

Koscumb, Stephen E. ;

Shah, Osama Shiraz ;

Chen, Fangyuan ;

Beriwal, Sushil ;

Diego, Emilia J. ;

Brufsky, Adam M. ;

Oesterreich, Steffi ;

Shapiro, Steven D. ;

Ferris, Robert ;

Emens, Leisha A. ;

Tseng, George ;

Marroquin, Oscar C. ;

Lee, Adrian V. ;

McAuliffe, Priscilla F. .

JAMA NETWORK OPEN, 2021, 4 (04)

[4] The duration of endocrine therapy and breast cancer patients' survival A nationwide population-based cohort study [J].

Chang, Chuan-Hsun ;

Huang, Chun-Wen ;

Huang, Chien-Ming ;

Ou, Tzu-Chi ;

Chen, Chu-Chieh ;

Lu, You-Min .

MEDICINE, 2019, 98 (43)

[5] Imaging Protocol and Criteria for Evaluation of Axillary Lymph Nodes in the NAUTILUS Trial [J].

Chang, Jung Min ;

Shin, Hee Jung ;

Choi, Ji Soo ;

Shin, Sung Ui ;

Choi, Bo Hwa ;

Kim, Min Jung ;

Yoon, Jung Hyun ;

Chung, Jin ;

Kim, Tae Hee ;

Han, Boo-Kyung ;

Kim, Hak Hee ;

Moon, Woo Kyung .

JOURNAL OF BREAST CANCER, 2021, 24 (06) :554-560

[6] Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base [J].

Chu, Quyen D. ;

Zhou, Meijiao ;

Medeiros, Kaelen L. ;

Peddi, Prakash ;

Wu, Xiao Cheng .

ANTICANCER RESEARCH, 2017, 37 (10) :5585-5594

[7] When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions [J].

Cortadellas, Tomas ;

Argacha, Paula ;

Acosta, Juan ;

Jurado, Judith ;

Peiro, Ricardo ;

Gomez, Margarita ;

Gonzalez-Farre, Xavier ;

Martinez, Milagros ;

Luna, Miguel ;

Peg, Vicente ;

Gil-Moreno, Antonio ;

Xiberta, Manel .

BREAST CARE, 2021, 16 (06) :630-636

[8] When is Sentinel Lymph Node Biopsy Useful in Ductal Carcinoma In Situ? The Experience at a Latin American Cancer Center [J].

Diaz Casas, Sandra E. ;

Serrano Munoz, Wilmar A. ;

Buelvas Gomez, Nelson A. ;

Osorio Ruiz, Ana M. ;

Angel Aristizabal, Javier ;

Guzman Abisaab, Luis H. ;

Garcia Mora, Mauricio ;

Lehmann Mosquera, Carlos ;

Cervera-Bonilla, Sergio ;

Sanchez Pedraza, Ricardo .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)

[9] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial [J].

Donker, Mila ;

van Tienhoven, Geertjan ;

Straver, Marieke E. ;

Meijnen, Philip ;

van de Velde, Cornelis J. H. ;

Mansel, Robert E. ;

Cataliotti, Luigi ;

Westenberg, A. Helen ;

Klinkenbijl, Jean H. G. ;

Orzalesi, Lorenzo ;

Bouma, Willem H. ;

van der Mijle, Huub C. J. ;

Nieuwenhuijzen, Grard A. P. ;

Veltkamp, Sanne C. ;

Slaets, Leen ;

Duez, Nicole J. ;

de Graaf, Peter W. ;

van Dalen, Thijs ;

Marinelli, Andreas ;

Rijna, Herman ;

Snoj, Marko ;

Bundred, Nigel J. ;

Merkus, Jos W. S. ;

Belkacemi, Yazid ;

Petignat, Patrick ;

Schinagl, Dominic A. X. ;

Coens, Corneel ;

Messina, Carlo G. M. ;

Bogaerts, Jan ;

Rutgers, Emiel J. T. .

LANCET ONCOLOGY, 2014, 15 (12) :1303-1310

[10] Factors Predictive of Positive Lymph Nodes for Breast Cancer [J].

Elleson, Kelly M. ;

Englander, Katherine ;

Gallagher, Julia ;

Chintapally, Neha ;

Sun, Weihong ;

Whiting, Junmin ;

Mallory, Melissa ;

Kiluk, John ;

Hoover, Susan ;

Khakpour, Nazanin ;

Czerniecki, Brian ;

Laronga, Christine ;

Lee, Marie Catherine .

CURRENT ONCOLOGY, 2023, 30 (12) :10351-10362

← 1 2 3 4 →